CClinicalTrials.gg
Status unknownNCT02330874Updated Jan 5, 2015

Validation of the SD-ICU. A Risk Assessment Tool of Unplanned ICU Readmission

An observational study in Critical Illness, sponsored by Hospital Sao Domingos. Status unknown at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-01-05.

Sponsored by Hospital Sao Domingos · Observational

The sponsor has not verified this record recently (last verified Dec 2014), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

In a recent study, which included 845 patients that at the time of ICU discharge had at least one risk factor for readmission, the investigators' group developed a new readmission risk score in the ICU, Safe Discharge from ICU (SD-ICU), using parameters easily and routinely measured in ICU: the Charlson comorbidity (ICC), the TISS-28 (Therapeutic Intervention Scoring System - 28), the length of stay in ICU and age. Through ROC curve analysis, the investigators found that patients with a score above 14.5 had a high probability of readmission.

The objective of this study is to validate the Safe Discharge from ICU (SD-ICU) score as a tool to predict unplanned readmissions to the intensive care unit.

All adult patients discharged from a 37 bed general ICU from April 2014 to March 2015 will be included in the study. The SD-ICU score is routinely calculated at the time of discharge from the ICU. Patients will be divided into two groups: those with SD-ICU score> 14.5 (group 1) and those with a score equal to or less than 14.5 (group 2). The two groups will be compared with respect to the frequency of unplanned readmissions. Stepwise, multivariate logistic regression will be used to investigate the association between the risk factors for readmission used in SD-ICU score and ICU readmission as outcome.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • Risk
  • score
  • readmission
  • ICU
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Hospital Sao Domingos is the lead sponsor of 23 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All adult patients discharged alive from a general ICU

Inclusion criteria

  • Adult patients discharged from a general ICU

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 years old
  • Those that were not candidates for ICU readmission (interhospital and home care transfer)
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Readmission to the ICU

    Time frame: After ICU discharge

07

Study locations

1 site
  • Hospital Sao Domingos
    Sao Luis, Maranhao 65060-645, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02330874
Lead sponsor
Hospital Sao Domingos
Responsible party
José Raimundo Araujo de Azevedo (PhD, Hospital Sao Domingos) — Principal investigator
First posted
Jan 5, 2015
Start date
Apr 2014
Primary completion
Mar 2015 (estimated)
Completion
Sep 2015 (estimated)
Last update
Jan 5, 2015

Study contacts

JOSE R AZEVEDO, PhD
principal investigator · Hospital Sao Domingos

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion